CN104644780A - Traditional Chinese medicine composition for treatment of prostatic hyperplasia - Google Patents
Traditional Chinese medicine composition for treatment of prostatic hyperplasia Download PDFInfo
- Publication number
- CN104644780A CN104644780A CN201510030982.3A CN201510030982A CN104644780A CN 104644780 A CN104644780 A CN 104644780A CN 201510030982 A CN201510030982 A CN 201510030982A CN 104644780 A CN104644780 A CN 104644780A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- prostatic hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treatment of prostatic hyperplasia, belonging to the field of traditional Chinese medicine. The traditional Chinese medicine composition is characterized by being prepared from the following traditional Chinese medicine raw materials: 4-8 parts of Cimicifuga, 20-40 parts of medicinal cyathula root, 10-20 parts of herba epimedii, 15-25 parts of dodder, 15-25 parts of Eclipta alba, 4-8 parts of leech, 4-8 parts of ground beeltle, 2-5 parts of pangolin, 20-40 parts of talc, 20-40 parts of Lygodium japonicum and 4-8 parts of amber. The traditional Chinese medicine composition has the functions of treating both symptoms and root causes, and combining dredging and tonifying effects, has remarkable treatment effect on prostatic hyperplasia, and has steady curative effect and no toxic or side effect.
Description
Technical field:
The present invention relates to a kind of Chinese medicine composition for the treatment of prostatic hyperplasia, belong to the field of Chinese medicines.
Background technology:
Prostatic hyperplasia is the common chronic disease of elderly men, and its sickness rate constantly raises with age, and symptom also increases the weight of with the growth at age.Prostatic hyperplasia main clinical manifestation is nocturia increased frequency, frequent micturition, urgent micturition, urine line attenuate, urine retention sense and can not suppress the lower urinary tract symptoms such as urine; normal with other complication as prostatitis, vesical calculus etc., had a strong impact on the sleep of patient, daily routines.
Prostatic hyperplasia is the uncontrolled non-malignant proliferative of body of gland inner cell, these proliferative cells are usually present in the surrounding tissue around urethra, along with constantly increasing the weight of of hypertrophy, body of gland can extrude urethra, and can urinary tract be blocked, cause bladder not to be emptied completely, so for infecting, vesical calculus and prostatiticly create condition.If do not treated, chronic obstruction also can cause urine to blow back into ureter, thus threatens the function of kidney.
At present, the treatment of prostatic hyperplasia mainly contains the kinds of schemes such as the minimally-invasive treatment of Drug therapy, operative treatment and newly-developed, but all unsatisfactory.Therefore a kind of simple and effective Chinese medicine treatment prostatic hyperplasia is found imperative.
Summary of the invention:
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of prostatic hyperplasia.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of prostatic hyperplasia, it is characterized in that being made up of the raw material of Chinese medicine of following parts by weight: Rhizoma Cimicifugae 4 ~ 8 parts, Radix Cyathulae 20 ~ 40 parts, Herba Epimedii 10 ~ 20 parts, Semen Cuscutae 15 ~ 25 parts, Herba Ecliptae 15 ~ 25 parts, Hirudo 4 ~ 8 parts, Eupolyphaga Seu Steleophaga 4 ~ 8 parts, Squama Manis 2 ~ 5 parts, 20 ~ 40 parts, Talcum, Spora Lygodii 20 ~ 40 parts, succinum 4 ~ 8 parts.
Preferably, the Chinese medicine composition for the treatment of prostatic hyperplasia of the present invention is made up of the raw material of Chinese medicine of following parts by weight: Rhizoma Cimicifugae 6 parts, Radix Cyathulae 30 parts, Herba Epimedii 15 parts, Semen Cuscutae 20 parts, Herba Ecliptae 20 parts, Hirudo 6 parts, Eupolyphaga Seu Steleophaga 6 parts, Squama Manis 3 parts, 30 parts, Talcum, Spora Lygodii 30 parts, succinum 6 parts.
Preparation method: said medicine ground to the powder altogether, water is general is ball, takes 3 day, each 10g, within 30 days, is a course for the treatment of.
In the present invention, Rhizoma Cimicifugae is up, and gas lift then water falls; Radix Cyathulae property is descending, two medicine one rise and one drop, is monarch drug altogether; The invigorating kidney-YANG of Herba Epimedii temperature, Semen Cuscutae YANG invigorating tonifying YIN, Herba Ecliptae nourishing YIN for benefiting the kidney, above three taste medicines share, and make tonifying both YIN and YANG, kidney qi obtains warm, bladder folding degree of having; Hirudo, Eupolyphaga Seu Steleophaga, Squama Manis share energy removing blood stasis eliminating stagnation; Talcum, Spora Lygodii energy clearing away damp-heat from lower-JIAO; Succinum can blood circulation promoting and blood stasis dispelling, again can clearing away heat-damp and promoting diuresis.
After said medicine combines by the present invention, have treating both the principal and secondary aspects of a disease, effect of through-supplementation, row gland hypertrophy aspect, achieves significant effect, stable curative effect, has no side effect before the treatment.
Below in conjunction with clinical trial and model case, the present invention will be further described.
One, clinical trial
1, clinical data: male prostatic hyperplasia patient 100 example choosing 49 years old ~ 79 years old, the course of disease differs in length.
2, Therapeutic Method: oral medicine of the present invention, takes 3 day, each 10g 30 days is a course for the treatment of.Take 3 courses for the treatment of altogether.
3, efficacy assessment standard:
Excellent: unobstructed micturition, strong, nocturia is less than 3 times.
Good: clinical symptoms is significantly improved, nocturia number of times obviously reduces, but still more than 3 times.
Difference: clinical symptoms is not improved or increases the weight of.
4, therapeutic outcome: after the treatment of 90 days, excellent 38 examples, good 57 examples, differ from 5 examples, total effective rate 95%.
Two, model case:
Example one: thank certain, man, 71 years old, patient because of the urine sound of rain pattering obstructed, trouble urinating is examined for more than 1 year, and B ultrasonic shows: prostatic hyperplasia, and give this traditional Chinese medicine composition for treating after 30 days, dysuria obviously alleviates, nocturia number of times reduce; Take this medicine and urinate basic recovery after 90 days normally, B ultrasonic shows: prostate comparatively before reduces, and follows up a case by regular visits to 1 year without recurrence.
Example two: grandson, man, 68 years old, over 2 years, urine discharges effort, even drop and under, little distention and fullness in the abdomen, during exacerbation of symptoms, urethral catheterization is needed to alleviate, give this traditional Chinese medicine composition for treating after 60 days, dysuria obviously alleviates, and nocturia number of times reduces, take this medicine to urinate after 90 days and basic recover normal, drug withdrawal so far there are no recurrence.
Example three: tall certain, man, 53 years old, suffers from dribbling urination not to the utmost for many years, increasingly increase the weight of in recent months, urinate need can emptying through more than 30 minutes at every turn, and take this Chinese medicine composition upon somebody's introduction after 30 days, the conscious prostatic of patient has movable sense, trouble urinating symptom significantly alleviates, after taking medicine 90 days, conscious unobstructed micturition is without hindrance, follows up a case by regular visits to 2 years without recurrence.
Detailed description of the invention:
Prepare medicine of the present invention: choose Chinese medicine Rhizoma Cimicifugae 6 parts, Radix Cyathulae 30 parts, Herba Epimedii 15 parts, Semen Cuscutae 20 parts, Herba Ecliptae 20 parts, Hirudo 6 parts, Eupolyphaga Seu Steleophaga 6 parts, Squama Manis 3 parts, 30 parts, Talcum, Spora Lygodii 30 parts, succinum 6 parts.For subsequent use.
Preparation and instructions of taking: medicine-feeding grinds to the powder altogether, and water is general is ball, takes 3 day, each 10g, within 30 days, is a course for the treatment of.
Claims (1)
1. treat a Chinese medicine composition for prostatic hyperplasia, it is characterized in that being made up of the raw material of Chinese medicine of following parts by weight: Rhizoma Cimicifugae 4 ~ 8 parts, Radix Cyathulae 20 ~ 40 parts, Herba Epimedii 10 ~ 20 parts, Semen Cuscutae 15 ~ 25 parts, Herba Ecliptae 15 ~ 25 parts, Hirudo 4 ~ 8 parts, Eupolyphaga Seu Steleophaga 4 ~ 8 parts, Squama Manis 2 ~ 5 parts, 20 ~ 40 parts, Talcum, Spora Lygodii 20 ~ 40 parts, succinum 4 ~ 8 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510030982.3A CN104644780A (en) | 2015-01-16 | 2015-01-16 | Traditional Chinese medicine composition for treatment of prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510030982.3A CN104644780A (en) | 2015-01-16 | 2015-01-16 | Traditional Chinese medicine composition for treatment of prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104644780A true CN104644780A (en) | 2015-05-27 |
Family
ID=53236749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510030982.3A Pending CN104644780A (en) | 2015-01-16 | 2015-01-16 | Traditional Chinese medicine composition for treatment of prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104644780A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1468619A (en) * | 2002-07-18 | 2004-01-21 | 上海雷允上药业有限公司 | Compound Chinese medicine prepn for treating benign prostate hyperplasia and its prepn process |
| CN103816363A (en) * | 2014-03-14 | 2014-05-28 | 庄妍 | Chinese herbal preparation for treating senile benign prostatic hyperplasia |
-
2015
- 2015-01-16 CN CN201510030982.3A patent/CN104644780A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1468619A (en) * | 2002-07-18 | 2004-01-21 | 上海雷允上药业有限公司 | Compound Chinese medicine prepn for treating benign prostate hyperplasia and its prepn process |
| CN103816363A (en) * | 2014-03-14 | 2014-05-28 | 庄妍 | Chinese herbal preparation for treating senile benign prostatic hyperplasia |
Non-Patent Citations (4)
| Title |
|---|
| 张继泽: "前列腺肥大所致癃痹辨治七法", 《江苏中医》 * |
| 王广超: "开癃启闭汤治疗前列腺肥大36例", 《新中医》 * |
| 高凤兰、崔茂香主编: "《病理学》", 31 August 2014, 第四军医大学出版社 * |
| 黄飞等: "中药复方治疗前列腺增生症概况", 《中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100531768C (en) | Medicament for treating chronic prostatitis and prostatic hyperplasia | |
| CN101972402A (en) | Chinese medicament for treating prostatitis | |
| CN101862428B (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN105327180A (en) | Traditional Chinese medicine preparation for treating kidney stones | |
| CN102949569A (en) | Traditional Chinese medicine composition for treating frequent micturition, urgent urination and micturition pain caused by benign prostatic hyperplasia | |
| CN101204532B (en) | Medicine for prostate disease and preparation method thereof | |
| CN102671091B (en) | Medicine composition for preventing surgical postoperative uroschesis | |
| CN104288296A (en) | Traditional Chinese medicine composition for treating cholelithiasis | |
| CN103751618A (en) | Calculus removing decoction for treating urinary calculus | |
| CN104644780A (en) | Traditional Chinese medicine composition for treatment of prostatic hyperplasia | |
| CN104069372B (en) | A kind of renal calculus Paishi Tang and instructions of taking thereof | |
| CN104000923B (en) | A kind of calculus of urethra Paishi Tang and instructions of taking thereof | |
| CN102846744B (en) | Drug for treating prostatic hypertrophy | |
| CN106492075A (en) | A kind of treat Chinese medicine composition of hyperplasia of prostate and preparation method thereof | |
| CN102698130B (en) | Traditional Chinese medicine extract for treating postoperative intestinal adhesion | |
| CN101579462A (en) | Medicine for treating prostatauxe and preparation method thereof | |
| CN101371900A (en) | Orally taken Chinese medicinal composition for treating constipation | |
| CN102145150B (en) | Medicine for treatment of uninary calculi | |
| CN101229238B (en) | Chinese traditional medicine preparation for treating prostate disease | |
| CN1279942C (en) | Decoction of Chinese traditional medicine for treating disease of senile acute urine retention | |
| CN104667027A (en) | Traditional Chinese medicine liquor for treating prostatic hyperplasia and preparation method of traditional Chinese medicine liquor | |
| CN101732624A (en) | Formula for treating ureteral calculi and preparation method thereof | |
| CN103585575B (en) | Traditional Chinese medicine composition for gallstone and prostatic hyperplasia | |
| CN102526564B (en) | Drug for treating vesical calculus | |
| CN105943744A (en) | Traditional Chinese medicine composition for treating retention of urine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150527 |